PV Bulletin
PvBulletin
Home /Regulators/Omnipod Insulin Management System Recall in Canada
RegulatorsHealth CanadaCanada

Omnipod Insulin Management System Recall in Canada

Health Canada posted a recall for Omnipod Insulin Management System due to product performance issues.

PV Impact Brief

Urgency: HighConfidence: high
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Action needed

Identify affected lots and implement recall procedures as per Health Canada guidelines.

Owner

Regulatory Intelligence Lead

Review cadence

action required within 24 hours

Regulatory action details

Action type
Health product recall
Publication date
2026-06-01
Safety issue
Recall for Omnipod Insulin Management System due to product performance issues.

Affected products

  • Omnipod Insulin Management System
    Insulet Corporation

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 1, 2026

Full briefing

What changed

Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.

Why it matters

Product performance issues may lead to insulin delivery errors, posing serious health risks to users.

Practical implication

Identify affected lots and implement recall procedures as per Health Canada guidelines.

#Safety Signals#Health product recall#Health Canada#safety_signal#firecrawl-agent#regulatory-extraction

Related updates for your role

RegulatorsMHRAUnited Kingdom

MHRA Class 2 Recall: ChloraPrep 2% applicators (potential sterility breach)

Regulatory action
Class 2 Medicines Recall
ChloraPrep 2% 1mL applicator · Becton Dickinson UK Ltd
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Identify and quarantine all impacted batches of ChloraPrep 2% 1mL and Frepp 2% 1.5mL applicators; return to Becton Dickinson UK Ltd.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
RegulatorsMedicines and Healthcare products Regulatory Agency (MHRA)United Kingdom

MHRA Largest Seizure of Unlicensed Weight Loss Medicines

Regulatory action
Enforcement Action / Public Safety Alert
Unlicensed weight loss medicines · Illicit manufacturing operation (unnamed)
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Review adverse event reports for potential links to counterfeit weight loss medicines; check product supply chain for unlicensed sources.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
RegulatorsFDAUnited States

FDA Public Notification: Tawon Liar Contains Hidden Drug Ingredients

Regulatory action
Public Notification
Tawon Liar
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Review product inventory for Tawon Liar; report any adverse events to FDA MedWatch; consider adding product to signal monitoring list; ensure labeling compliance checks for similar products.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
RegulatorsEuropean Medicines Agency (EMA)European Union

EMA ETF recommends updating COVID-19 vaccines to target XFG variant for 2026/2027 campaign

Regulatory action
Regulatory Recommendation / Public Health Communication
COVID-19 vaccines · Marketing authorisation holders (various)
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Marketing authorisation holders should prepare to update their COVID-19 vaccines to target the XFG variant for the upcoming campaign; monitor for further regulatory guidance and prepare for potential strain change submissions.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: MonitorConfidence: high
Read impact brief →
Omnipod Insulin Management System Recall in Canada | PV Bulletin